Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus.

Cochrane database of systematic reviews (Online)

Volumn , Issue 3, 2000, Pages

  Trevisani, V F ^a   Castro, A A ^a   Neves Neto, J F ^a   Atallah, A N ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT;

COGNITIVE DEFECT; CRANIAL NEUROPATHY; HUMAN; REVIEW; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIRHEUMATIC AGENTS; CRANIAL NERVE DISEASES; CYCLOPHOSPHAMIDE; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; SEIZURES;

EID: 84921432631     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (31)